Standardized incidence ratio peaked in patients who underwent transplantation in 1983-1987 period.
Key changes include new N category descriptors, more stage III subgroups, new M1D designation.
Limiting cold ischemia times could increase the use of renal allografts donated from patients after death from cardiovascular causes, researchers say.
Kidney transplant recipients who experience recurrent urinary tract infections are at increased risk of graft failure and death.
Hemodialysis patients had higher rates of infective endocarditis than peritoneal dialysis and kidney transplant patients.
Score for subscale of perceived seriousness for no reduction of salt intake higher in transplant patients.
Each 1-mg/dL increase in serum phosphorus among kidney transplant recipients is associated with 36% and 21% increased risk in graft failure and death, respectively.
Biopsy-guided allocation of kidneys from octogenarian donors permits further expansion of the donor-organ pool.
There was a correlation for later acceptance in the match-run with delayed graft function, but not with all-cause graft failure.
IdeS reduced or eliminated donor-specific antibodies and permitted HLA-incompatible transplantation.
Risk factors include older age, white race, and receiving a kidney from a living donor.
Increased risk of allograft loss, death for HIV-positive patients receiving protease inhibitor ART.
Most lower-quality kidneys also remained viable for nearly as long as the best kidneys, with 73.2% still working 5 years after transplant.
The researchers observed a narrowing of disparities in the average monthly transplantation rates with implementation of the new system.
Up to half of transplant patients might experience tertiary hyperparathyroidism.
Overall, recipients of diabetic donor kidneys had a 9% lower chance of dying compared with remaining on the waitlist.
During the observation period, the researchers found that 77.5%, 69.8%, and 91.4% of SOTRs were not up-to-date for colorectal, cervical, and breast cancer screening tests, respectively.
Early data from the study revealed this treatment effectively cleared hepatitis C from all of the patients.
NODAT occurred more frequently in the upper PCSK9 tertile vs the lowest two PCSK9 tertiles.
In a study, obese transplant recipients with low muscle mass had an increased risk of death but not graft loss.
The incidence of NODAT was 33.8% among patients who switched to everolimus and 36.4% among those who stayed on calcineurin inhibitors.
Opportunistic viral and fungal infections or malignancies develop in 34% of kidney transplant recipients, but these complications do not affect patient or graft survival.
Post-transplant UTI rates were lower when cephalexin was added to SMX-TMP than when SMX-TMP was used alone (7.5% vs 25.8%), study finds.
In a study, diabetes in both the donor and recipient was associated with triple the risk of death at 5 years post-transplant compared with the absence of diabetes in both the donor and recipient.
Highest level of opioid use in the year prior to transplantation was associated with a 45% and 28% increased risk of death and graft loss, respectively.
Kidney transplant recipients who experienced an episode of bacteremia had double the risks of graft failure and death.
Older patients with a Charlson Comorbidity Index score below 5 had a higher 3-year survival rate than those with a score of 5 or higher (90% vs 76%).
High-KDPI kidneys can improve the likelihood of a functioning graft compared with waiting for a superior kidney.
Venous thromboembolism is associated with a 4.1-fold increased risk of death and a 2.3-fold increased risk of death-censored graft loss among kidney transplant recipients.
Risk factors include impaired renal function and inadequate hydration prior to contrast exposure.
Renal and Urology News Articles
Sign Up for Free e-newsletters
NEPHROLOGY & UROLOGY NEWS
- Acute Kidney Injury (AKI)
- Chronic Kidney Disease (CKD)
- Contrast Nephropathy
- Cardiovascular Disease (CVD)
- Diabetic Nephropathy
- End-stage Renal Disease (ESRD)
- Lupus Nephritis
- Peritoneal Dialysis
- Secondary Hyperparathyroidism (SHPT)